Pharmaceutical Pricing and Contracting Strategy Analyst

Pricing and market access directors at pharmaceutical companies preparing for launch of a novel specialty or rare disease drug use this agent to develop the US gross-to-net pricing architecture, contracting strategy for PBM formulary inclusion, and value-based contract framework aligned to payer evidence requirements.